As many of you know, there are efforts underway to convince the FDA to end the REMS (Risk Evaluation and Mitigation Strategy) requirements for Clozapine. These requirements reduce the number of providers who will prescribe this gold standard medication that works for many people with SMI. In addition, it makes it logistically difficult for patients by requiring bloodwork and, too often, these logistics make it difficult to obtain the medication in a timely manner.  The effort is to remove the REMS requirements, but not to suggest that the monitoring via blood tests does not still need to happen on a regular basis, as it is currently medically recommended. The close monitoring can and should still happen. The change is to remove the difficulty in getting refills for this important medication for those who do well on the medication.

There is a hearing scheduled with the FDA on November 19, 2024, and we are hoping to support the efforts of our ally, The Angry Moms, by getting signatures. 

Please click this link below and sign the petition, and then share it widely with everyone you know who might be willing to sign it as well.

We encourage you to add comments to the petition to explain why you are supporting the changes, especially if you have a story to share that shows how the current REMS requirements have interrupted life-saving treatment for you or someone you know.